Biogen Stock Surges As FDA Fast-Tracks Alzheimer's Drug Application

Biogen Stock Surges As FDA Fast-Tracks Alzheimer's Drug Application

Biogen stock powered up Friday after the firm said the U.S. Food and Drug Administration has decided to fast-track its application to bring a new Alzheimer's disease drug to market.